Tumor banks for genomic and proteomic research

Celis JE, Kruhoffer M, Gromova I, et al. Gene expression profiling: Monitoring transcription and traslation products using DNA microarrays and proteomics. FEBS Lett 2000;480:2–16. Celis JE. A new start in Madrid: Symposium on basic and traslational cancer research. EMBO Rep 2002;3:718–23. Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinoma. Moll Cell Proteomics 2002;1:304–13. Celis JE, Gromov P. Proteomics in traslational cancer research: Towards an integrated approach. Cancer Cell 2003;3:9–15. Michener CM, Ardekani AM, Petricoin EF 3rd, Liotta LA, Kohn EC. Genomics and proteomics: Application of novel technology to early detection and prevention of cancer. Cancer Detect Prev 2002;26:249–55. Van de Vijver MJ, He YD, van't Veer LJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999–2009. Ma XJ, Salunga R, Tuggle JT, et al. Gene expresion profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003;100:5974–9. Ferea TL, Brown PO. Observing the living genome. Curr Opin Genet Dev 1999;9:715–22. Baak JPA, Path FRC, Hemsen MAJA, Meijer G, Schmidt J, Janssen EAM. Genomics and proteomics in cancer. Eur J Cancer 2003;39:1199–215. Hair JF, McNicol AM, Guterson BA. Is research on human tissues at a crossroads? Eur J Cancer 2003;39:2253–5. Oosterhuis JW, Coebergh JW, van Veen EB. Tumor Banks: well-guarded treasures in the interest of patients. Nat Rev Cancer 2003;3:73–7. Morente MM, Alonso S. Bancos de tumores y oncopatología en el siglo XXI. Red de bancos de tumores y programa de patología molecular del CNIO. V congreso virtual hispanoamericano de Anatomía Patológica; 2003, septiembre [online], (cited 14-03-2004). Available from: http://congannat.uninet.edu/conferencia/C008 Teodorovic I, Therasse P, Spatz A, Isabelle M, Oosterhuis W. Human tissue research: EORTC recommendations on its practical consequences. Eur J Cancer 2003;39:2256–63. Burbaum J, Tobal GM. Proteomics in drug discovery. Curr Opin Chem Biol 2002;26:249–55. Witzmann FA, Grant RA. Pharmacoproteomics in drug development. Pharmacogenomics 2003;2:69–76. Bleicher KH, Bohm HJ, Mueller K, Alanine AI. Hit and lead generation: Beyond high-throughput screening. Nat Rev Drug Discov 2003;2:369–78. Becich MJ. The role of the patologist as tissue refiner and data miner: the impact of funtional genomics on the modern pathology laboratory and the critical roles of pathology informatics and bioinformatics. Mol Diagn 2000;5:287–99. Celis JE, Gromov P, Gromova I, et al. Integrating proteomic and funtional genomic technologies in discovery-driven traslational breast cancer research. Moll Cell Proteomics 2003;2:369–77. Adam D. Online tumors banks aims to offer ready route to tissues. Nature 2002;416:64. Morente MM. La red de bancos de tumores. Programas cientificos del CNIO [on line]; (cited 14-03-2004). Available from: http://www.cnio.es/es/progtumor01.htm Grady C. Ethics and genetic testing. Adv Intern Med 1999;44:348–411. Burgess MM. Beyond Consent: ethical and social issues in genetic testing. Nat Rev Genet 2001;2:147–51. Genetic Interest Group. Confidentiality guidelines: confidentially and medical genetics [online] 1999; (cited 10-3-2004). Available from: http://www.gig.org.uk/docs/gig-confidentialy.pdf Reilly PR. Legal issues in Genomic Medicine. Nat Med 2001;7:268–71. Instrumento de ratificación del Convenio para la proteción de los derechos humanos y la dignidad del ser humano con res Oviedo, 4 de Abril de 1997. BOE n.o251 de 20 de Octubre de 1999. UNESCO (1997). Universal Declaration of the Human Genoma and Human Rights [on line] 1997, November 11; París (cited 17-03-2004). Available from: http://www.unesco.org/ibc/en/genome/project/index.html White MT. Underlaying ambiguities in genetic privacy legislation. Genet Testing 1999;3:341–5. Scully JL. Drawing a line: situating moral boundaries in genetic medicine. Bioethics 2001;15:189–204. Health Council (Gezondheidsraad). Towards proper use. The Hague: Gezondheidsraad, 1994. Nuffield Council on Bioethics. Human tissue, Ethical and Legal issues. London: Nuffield Council on Bioethics, 1995. Human Genomics Organisation (HUGO) Ethics Committee. Statement on DNA sampling: Control and Access [on line], 1998; (cited 17-03-2004). Available from: http://www.hugo-international.org/hugo/sampling.html European Group on Ethics and aspects of tissue banking, opinion no11, to the European Comission, 21 july 1998. Medical Research Council of Canada, Natural Sciences and Engineering Research Council of Canada. Social Sciences and Humanities Research Council of Canada, Tri Council Policy Statement Ethical Conduct for research involving Human Subjects, especially section 10 [on line], 1998 (revised in 2000); (cited 17-03-2004). Available from: http://www.nserc.ca/programs/ethics/english/policy.html National Bioethics Advisory Commission, research involving human biological materials: Ethical issues and policy guidance, Rockville, Maryland: National Bioethics Advisory Comission, vol. 1. [on line], August 1999; (cited 17-03-2004). Available from: http://www.georgetown.edu/research/nrcbl/nbac/ Medical Research Council. Human Tissue and biological samples of use in research. Medical Research Council, London [on line], 2001; (cited 17-03-2004). Available from: http://www.mrc.ac.uk Parlamento Europeo. Informe PE 300.127, de 8 de Noviembre de 2001, sobre las repercusiones éticas, jurídicas y económicas y sociales de la genética humana. Comisión Temporal sobre genética humana y otras nuevas tecnologías de la medicina moderna. American College of Medical Genetics (ACMG). Rapid action task force on informed consent for genetic research. Statement on informed consent for genetic research. Am J Hum Genet 1996;59:471–4. The National Human Genome Research Institute. Policy Recommendations [on line]; [cited 17-03-2004]. Available from: http://www.nhgri.nih.gov Statement of the WHO Expert Consultation on New Developments in Human Genetics. WHO-invited experts: 2000; July 20–21; Geneve [cited 17-03-2004]. Available from: http://www.who.int Genetic Testing, Screening and “eugenics”. A genetic Interest Group Policy Paper [on line] 1999, November; (cited 17-03-2004). Available from: http://www.gig.org.uk NIH. Development of a Classification Methodology for Genetic Test: conclusions and recommendations of the Secretary' Advisory Committe on Genetic Testing [on line], 2001, September; (cited 17-03-2004). Available from: http://www.od.nih.gov/oba/sacgt.html Department of Health. Human Genetic Commission (HCG). Protection of genetic information: an international comparison [on line], 2000, September; (cited 17-03-2004). Available from: http://www.hgc.gov.uk/business publications.html Knoppers BM, Hirtle M, Lormeau S, Laberge CM, Laflamme M. Control of DNA samples and information. Genomics 1998;50:385–401. American Association of Medical Colleges (AAMC). Executive Council. Medical records and genetic privacy. Health data security, patient privacy, and the use of archival patient materials in research. Washington DC: American Medical Association, 1997. American College of Medical Genetics (ACMG). Ad Hoc Committee on DNA Technology. DNA banking and DNA analysis. Points to consider. Am J Hum Genet 1988;42: 781–3. Clayton EW, Steinberg KK, Khoury MJ, et al. Informed consent for genetic research on stored tissue samples. JAMA 1995;274:1786–92. European Society of Human Genetics. Public and Professional fessional Policy Committe (PPPC). Data storage and DNA banking for biomedical research. Proposed recommendations of the European Society of Human Genetics. August 2001. UNESCO. International Bioethics Committee. Working Group of IBC on genetic Data. Draft Report on Collection, treatment, storage and use of genetic data. París, 2001 September. UNESCO. International Bioethics Committee. Working Group of IBC on the follow-up of the International Symposium on Ethics, Intellectual Property and Genomics. Draft Report. August 2001. The NCI-Cooperative Human Tissue Network (CHTN) requires compliance with the US DHHS policy for the protection of human subjects for use of tissue from the listed repositories [on.line]; (cited 17-03-2004). Available from: http://ohrp.osophs.dhhs.gov/human subjects/guidance/45cfr46.html Baeyens AJ, Hakimian R, Spatz A, Aamodt R. Use of human biological samples in research: a comparison of the laws in the Use and Europe. Biosci Law Rev 2003; 11. Declaración de Helsinki de la Asociación Médica Mundial. Principios éticos para las investigaciones médicas en seres humanos. Adoptada por la 18a Asamblea Médica Mundial. Finlandia 1964, Junio y posteriores revisiones (1975, 1983, 1989, 1996, 2000); Helsinki, [cited 17-03-2004]. Available from: http://www.wma.net/s/policy/17-c-s.html Rodríguez-Villanueva J, Alsarb MJ, Avedañoc C, Gómez-Piqueras C, García-Alonso F. Estudios farmacogenéticos: guía de evaluación para Comités Éticos de Investigación Clínica. Fundamentos científicos y marco legal. EE-CC Revista de los ensayos Clínicos [serial on line] 2003; (cited 17-03-2004). Available from: http://ee-cc.net/ee-cc2/home.asp The European Union. Directive 95/46/EC on the protection of individuals with regard to the processing of personal data and on the free movement of such data [on line]; (cited 11-03-2004). Available from: http://www.privacy.org/pi/intl_orgs/ec/eudp.html Rynning E. The new swedish act on biobanks in health care-privacy versus freedom of research revisited. Book of Proceedings II, 14th World Congress on Medical Law: 2002, August 10–15; Maastricht. Maastrict: MECC, 2002. Saul H. News. Eur J Cancer 2003;39:551–5. Theilade MD, Knudsen LE, Renneberg J. Regulatory requirements for inclusion of Pharmacogenetic testing in applications for clinical trials in Europe. Regul Affairs J 2001;12:92–9. Loi no 88-1138 du 20 décembre 1988 relative à la protection des persones qui se prétent à des recherches biomédicales (Journal Officiel, 22 décembre 1988) modifieé par la loi n0 90–86 du 23 janvier 1990 (Journal Officiel, 25 janvier 1990), la loi n0 90–549 du 2 julliet 1990 (Journal Officiel, 5). Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine [on line]; (cited 17-03-2004). Available from: http://conventions.coe.int/treaty/en/treaties/html/164.html Real Decreto 561/1993, 16 de Abril, por el que se establecen los requisitos para la realización de ensayos clínicos. BOE de 13 de mayo de 1993. Ley orgánica 15/1999, de 13 de diciembre, de Protección de Datos de Carácter Personal. BOE de 14 de diciembre de 1999. Directiva 95/46/CE del Parlamento Europeo y del Consejo de 24 de octubre de 1995, relativa a la protección de las personas. Diario Oficial de las Comunidades Europeas, 23 de noviembre de 1995, no L281:31-50. Real Decreto 994/1999 de 11 de junio. Reglamento de medidas de seguridad de los ficheros automatizados que contengan datos de carácter personal. Ministerio de Justicia. BOE de 25 de junio de 1999. Recomendación R (97) 5, de 13 de febrero de 1997, del Comité de Ministros del Consejo de Europa, 1997. Rothstein MA, Epps PG. Ethical, and legal implications of pharmacogenomics. Nat Rev Genet 2001;2:238–41. March R, Cheeseman K, Diherty M. Pharmacogenetics-legal, ethical and regulatory considerations. Pharmacogenomics 2001;2:317–27. Robertson JA; Consent and Privacy in pharmacogenetic testing. Nat Genet 2001;28:207–9. Act on Biobanks No. 110/2000 [on line]; (cited 10-17-2004). Available from: http://ministryofhealth.is/interpro/htr/htr.nsf/pages/Act-biobanks Federation of Medical Scientific Societies in The Netherlands. Code for proper use (FMWW, Rotterdam, 2002) [on line]; (cited 17-03-2004). Available from: http://www.fmw.nl Owen D. Pateting human genes (National Institute for Medical Research) [on line]; (cited 17-03-2004). Available from: http://www.nimr.mrc.ac.uk/MillHillEssays/ 1995/genepat.html Directive 98/94/EC on the protection on biotechnological inventions, L.213/13 [on line]; (cited 17-03-2004). Available from: http://europa.eu.int/eur-iex/pri/en/oj/dat/1998/l_213/l_21319980en00130021.pdf Decision in case C-377/98 of the European Court of Justice [on line]; (cited 17-03-2004). Available from: http://curia.eu.int/jurisp/cgi-bin/form.pl?lang=en The President's Council on Bioethics. Pattenting Human Organisms. Staff Working Paper no 8 [on line]; (cited 17-04-2004). Available from: http://www.bioethics.gov/workpaper8.html Article 21 of The European Convention on Human Rights and Biomedicine [on line]; (cited 17-03-2004). Available from: http://conventions.coe.int/Treaty/EN/ CadreListeTraites.html The NCI-CHTN, ref. 13 supra, policy on this subject [on line]; (cited 17-03-2004). Available from: http://www.chtn.ims.cni.gov/commercial.html The NIH Guide for Grants and Contracts: Objectivity in Research [on line]; (cited 17-03-2004). Available from: http://grants2.nih.gov/grants/guide/notice-fites/NOTOD-00-040.html Massachusetts Institute of technology conflict of interest policy [on line]; (cited 17-03-2004). Available from: http://web.mit.edu/policies/4.4.html International Committee of medical journals editors. Uniform requirements for manuscrispt submitted to medical journals. Ann Intern Med 1998;108:253–304.